ATPase H+ transporting V0 subunit a3 (ATP6V0A3)

ATPase H+ transporting V0 subunit a3 (ATP6V0A3), encoded by the TCIRG1 gene, is a critical component of the membrane-integral V0 domain of the vacuolar-type H+-ATPase (V-ATPase) complex [2, 4]. This multisubunit enzyme acts as an ATP-driven proton pump, essential for acidifying intracellular organelles such as lysosomes and endosomes, as well as the extracellular environment in specialized cells [5, 15]. In osteoclasts, the a3 subunit is highly expressed and localizes to the ruffled border, where it pumps protons into the resorption lacuna to dissolve bone mineral [4, 10]. Mutations in TCIRG1 are the primary cause of autosomal recessive infantile malignant osteopetrosis, a severe disease characterized by defective bone resorption and increased bone density [7, 10]. Furthermore, the a3 subunit is frequently upregulated in various cancers, where it contributes to an acidic microenvironment that facilitates tumor invasion, metastasis, and resistance to chemotherapy [5, 13]. Therapeutic strategies targeting this subunit, including small molecules like enoxacin that disrupt specific subunit interactions, are being investigated for the treatment of osteoporosis and metastatic cancer while aiming to minimize the systemic toxicity associated with pan-V-ATPase inhibition [1, 13].

Other names

TCIRG1T cell immune regulator 1OC116OC-116TIRC7ATP6N1CAtp6iOPTB1a3

Inhibition of V-ATPase-mediated proton translocation and disruption of subunit interactions (e.g., a3-B2) to prevent acidification of the bone-resorption lacuna or tumor microenvironment [1, 13].